AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (919.8 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese | Open Access

Age-stratified analysis of cervical cancer screening effectiveness in Yuhuatai District, Nanjing

Jinhong Zhang1, Jing Jiang2, Jing Bai1, Lijun Zhu3, Xuemei Fan4, Yi Jin2 ( ), Qiang Li5 ( )
Department of Women’s Health Care, Yuhuatai District Maternity and Child Health Care Hospital, Nanjing 210012
Department of Information Center, the Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University (Nanjing Women and Children’s Healthcare Hospital), Nanjing 210004
Medical Research Center, the Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University (Nanjing Women and Children’s Healthcare Hospital), Nanjing 210004
Department of Nursing, the Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University (Nanjing Women and Children’s Healthcare Hospital), Nanjing 210004
Department of Obstetrics and Gynecology, the Drum Tower Hospital Affiliated to Nanjing University Medical School (Nanjing Drum Tower Hospital), Nanjing 210008, China
Show Author Information

Abstract

Objective

To investigate the age-stratified characteristics of high-risk human papillomavirus (hrHPV) infection in women and compare the detection efficacy of three screening protocols in detecting cervical cancer (CC) and precancerous lesions across different age groups, to provide a basis for optimizing CC screening strategies.

Methods

A retrospective analysis was conducted on CC screening data from 22540 women aged 35-64 years enrolled in Nanjing’s cervical and breast cancer screening program from 2023 to 2024. Participants were divided into two age groups using the average menopausal age of 50 years as the cut-off: 35-49 years (n=11539) and 50-64 years (n=11001). The positive rates of hrHPV 16/18 and the detection rates of cervical intraepithelial neoplasia grade 2 (CIN2) or worse (CIN2+) were compared between the two age groups. Three screening protocols were compared: ThinPrep cytologic test (TCT)-based initial screening, hrHPV-based initial screening, and combined hrHPV and TCT initial screening (referred to as “combined screening”). The CIN2+ detection rates were compared among the three protocols followed by further age-stratified analysis. The chi-square test was used to compare positive rates and detection rates between groups, and Bonferroni correction (α’=0.0167) was used for pairwise comparisons if there was a statistically significant difference, with further age-stratified analysis. Logistic regression analysis was applied to adjust for confounding factors and evaluate the differences in screening effectiveness after age stratification.

Results

Age-stratified comparison showed that the positive rate of hrHPV 16/18 was significantly higher in the 50-64 age group than in the 35-49 age group (2.1% vs. 1.6%, χ2=4.668, P=0.031), while there was no statistically significant difference in the CIN2 + detection rate between the two age groups (0.4% vs. 0.5%, χ2=0.210, P=0.647). There was a statistically significant difference in the CIN2 + detection rate among the three screening protocols (χ2=23.411, P<0.001). After Bonferroni correction, pairwise comparisons indicated that both combined screening and hrHPV initial screening had significantly higher CIN2+ detection rates than TCT initial screening (corrected P<0.001 for both P<α’), and there was no statistically significant difference between hrHPV initial screening and combined screening (corrected P=0.174, P>α’). After age stratification, in the 35-49 age group, the CIN2+ detection rate of combined screening was higher than that of hrHPV initial screening (0.9% vs. 0.5%, χ2=4.372, P=0.037), whereas in the 50-64 age group, there was no significant difference in the CIN2+ detection rates between the two protocols (0.6% vs.0.4%, χ2=0.536, P=0.464). The aforementioned age-stratified results were consistent after multivariate logistic regression adjustment.

Conclusion

Combined screening is recommended for women aged 35-49 to improve the detection rate of CC and precancerous lesions, while hrHPV initial screening may be prioritized for women aged 50-64. An age-stratified screening strategy can enhance the precision of CC screening and improve resource utilization efficiency.

CLC number: R737.33 Document code: A Article ID: 1007-4368(2026)11-1603-08

References

【1】
【1】
 
 
Journal of Nanjing Medical University (Natural Sciences)
Pages 1603-1609

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhang J, Jiang J, Bai J, et al. Age-stratified analysis of cervical cancer screening effectiveness in Yuhuatai District, Nanjing. Journal of Nanjing Medical University (Natural Sciences), 2026, 46(11): 1603-1609. https://doi.org/10.7655/NYDXBNSN251427

3

Views

0

Downloads

0

Crossref

Received: 20 December 2025
Revised: 25 April 2026
Accepted: 10 May 2026
Published: 15 November 2026
© 2026 Editorial Board of Journal of Nanjing Medical University(Natural Sciences)

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).